Ultragenyx Pharmaceutical
RARE
#3771
Rank
โ‚น300.25 B
Marketcap
โ‚น3,112
Share price
3.73%
Change (1 day)
-16.49%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: โ‚น300.25 Billion

As of December 2025 Ultragenyx Pharmaceutical has a market cap of โ‚น300.25 Billion. This makes Ultragenyx Pharmaceutical the world's 3771th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น300.25 B-12.71%
2024โ‚น343.96 B5.22%
2023โ‚น326.89 B21.63%
2022โ‚น268.77 B-37%
2021โ‚น426.62 B-36.3%
2020โ‚น669.75 B280.2%
2019โ‚น176.15 B13.92%
2018โ‚น154.62 B22.6%
2017โ‚น126.12 B-35.4%
2016โ‚น195.22 B-32.65%
2015โ‚น289.86 B226.38%
2014โ‚น88.81 B

End of Day market cap according to different sources

On Dec 21st, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

โ‚น289.45 Billion
by Nasdaq info icon info icon
โ‚น289.45 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚น1.019 T 239.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น392.65 B 30.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น85.77 B-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น39.70 B-86.78%๐Ÿ‡บ๐Ÿ‡ธ USA